Literature DB >> 12359115

Management of asthma in young children.

Marianna Sockrider1.   

Abstract

Asthma and recurrent airway symptoms in a young child can result in significant morbidity and reduced quality of life. There is significant variability in asthma severity. Even for those who will "outgrow" asthma, regular problems can be minimized with appropriate pharmacotherapy, education, and environmental control. Success with primary prevention through environmental control for children at high risk for asthma has been limited. Avoidance of passive tobacco smoke exposure has primary and secondary prevention benefits. An inhaled short-acting bronchodilator should be available for use as needed. Patients with regular symptoms should receive maintenance anti-inflammatory medication. Add-on therapy can be considered for those with inadequate control on inhaled corticosteroid. Physicians should regularly review drug delivery technique and compliance and provide all patients with a written asthma action plan to guide symptom monitoring and medication use. Physicians should also establish a partnership with the child and family, providing self-management training to enhance skills and confidence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359115     DOI: 10.1007/s11882-002-0084-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  62 in total

1.  The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children.

Authors:  K G Nielsen; H Bisgaard
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects.

Authors:  S P Newman; M T Newhouse
Journal:  J Aerosol Med       Date:  1996

3.  Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study.

Authors:  R T Stein; C J Holberg; D Sherrill; A L Wright; W J Morgan; L Taussig; F D Martinez
Journal:  Am J Epidemiol       Date:  1999-06-01       Impact factor: 4.897

Review 4.  Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review.

Authors:  M J Tasche; J H Uijen; R M Bernsen; J C de Jongste; J C van der Wouden
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 5.  Role of respiratory infection in onset of asthma and chronic obstructive pulmonary disease.

Authors:  F D Martinez
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

6.  Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers.

Authors:  J H Wildhaber; S G Devadason; M J Hayden; E Eber; Q A Summers; P N LeSouëf
Journal:  Pediatr Pulmonol       Date:  1997-03

7.  Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits.

Authors:  T A Lieu; C P Quesenberry; A M Capra; M E Sorel; K E Martin; G R Mendoza
Journal:  Pediatrics       Date:  1997-09       Impact factor: 7.124

8.  Education of parents of infants and very young children with asthma: a developmental evaluation of the Wee Wheezers program.

Authors:  S R Wilson; D Latini; N J Starr; L Fish; L M Loes; A Page; P Kubic
Journal:  J Asthma       Date:  1996       Impact factor: 2.515

9.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

Authors:  L Agertoft; S Pedersen
Journal:  Respir Med       Date:  1994-05       Impact factor: 3.415

10.  An education program for parents of children with asthma: differences in attendance between smoking and nonsmoking parents.

Authors:  L Fish; S R Wilson; D M Latini; N J Starr
Journal:  Am J Public Health       Date:  1996-02       Impact factor: 9.308

View more
  1 in total

1.  Partner randomized controlled trial: study protocol and coaching intervention.

Authors:  Jane M Garbutt; Gabrielle Highstein; Yan Yan; Robert C Strunk
Journal:  BMC Pediatr       Date:  2012-04-02       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.